In-line plasma filter

Leukodepletion is a major step to improve transfusion safety thanks to a significant reduction of patient adverse reactions and pathogen transmissions.

Macopharma develops and manufactures leukodepletion systems to improve the quality and the safety of blood components, allowing better patient outcome.

Please enable JavaScript in your browser to complete this form.

Download eCatalogue

A valid email is required. You will receive a link to download the eCatalogue in your mailbox.


NPT system for leucoreduced plasma, buffy coat
and leucoreduced Red Blood Cells concentrate preparation


High leukodepletion performance

Plasmaflex Miniplas provides high performance far below the Europeanrequirement 1 x 106/unit WBC/unit

Compliance with all the European guidelines parameters for fresh frozen plasma

High blood component recovery > 95%

Allow plasma cells and fragment removal

Maintain plasma biochemical and labile coagulation factors


Soft housing filter for easy & secure handling

Design allowing transparent housing for visual monitoring of filtration

Fast filtration process


Macopharma is a major global player in the filtration of blood components, with unique know-howand expertise. We have a deep understanding of your requirements and strive to provide you with reliable and robust filters, guaranteeing high performance stability and reproducibility.

This information is for exclusive use of healthcare professionals.
The products are not available in every country, please contact your sales representative.
MACOPHARMA • Rue Lorthiois 59240 Mouvaux France • Tel : + 33 (0) 3 20 11 84 00 • Fax : +33 (0) 3 20 11 84 03
Société par actions simplifiée au Capital de 493.115 € RCS Lille Metropole 391 600 905 • Code APE 4641 Z • TVA FR 313 916 009 05